Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FTSE 100 reverses course to end lower on Imperial slump

Published 20/02/2020, 17:17
Updated 20/02/2020, 17:17
© Reuters. FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain

By Shashwat Awasthi and Muvija M

(Reuters) - London's FTSE 100 handed back earlier gains to record losses on Thursday as a 7.3% fall in tobacco giant Imperial Brands overshadowed a 10% leap in medical products maker Smith+Nephew.

The blue-chip index (FTSE) slipped 0.3% as Imperial Brands (L:IMB) tumbled on ex-dividend trading, while most other sectors also traded in the red with a surge in coronavirus infections in South Korea stoking fears about a deepening health crisis.

Smith+Nephew (L:SN) hit an all-time high and helped limit losses on the index after the medical products maker forecast another year of revenue growth.

The FTSE 250 midcap index (FTMC) ended the day with a 0.1% rise, led by a 19% surge in price comparison website Moneysupermarket.com (L:MONY) following upbeat outlook and a 7% jump in engineering firm Spectris (L:SXS) after 2019 results.

For the most part, the British indexes have drawn support this week from stimulus measures from China, which cut its benchmark lending rate to cushion the impact of the coronavirus epidemic.

Both indexes are headed for a week of gains.

"Investors are making a number of significant assumptions that governments and central banks will be able to mitigate the effects of any disruption in the short and medium term," CMC Markets analyst Michael Hewson said.

"Time will tell whether that is a safe assumption to make, however in the absence of anywhere else to put one's money, the line of least resistance for now appears to be to buy stocks."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among other notable gainers on the main index were defence firm BAE Systems (L:BAES) and lender Lloyds (L:LLOY) with gains of 3% and 1.4%, respectively, after their annual results.

However, the FTSE 100's losses were deepened by 1%-1.7% falls in GlaxoSmithKline (L:GSK) and Unilever (L:ULVR), whose stocks also traded without dividend entitlement.

Small-cap bathroom and kitchen products supplier Norcros (L:NXR) slid 11% after it warned annual profit would miss market expectations and supply chain disruptions due to the coronavirus outbreak would likely hit performance.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.